Preferred Label : Bag;
NCIt definition : A sac or pouch.;
Alternative definition : EDQM-HC: Container consisting of surfaces, whether or not with a flat bottom, made
of flexible material, generally closed at the bottom and at the sides by sealing;
at the top possibly to be closed by fusion of the material, depending on the intended
use. Equipped with special attachments. Contains the final preparation in one compartment
or the components necessary for its preparation in different compartments.;
FDA table : Package Type (C-DRG-00907);
Codes from synonyms : 30004000;
Origin ID : C43167;
UMLS CUI : C0179196;
Automatic exact mappings (from CISMeF team)
- Bag [EDQM-ST unit of presentation]
Currated CISMeF NLP mapping
Semantic type(s)
UMLS correspondences (same concept)
concept_is_in_subset
https://www.cfp.ca/content/70/2/e42
2024
Canada
journal article
Pouch
Human Immunodeficiency Virus
Prevention Study
Central Nervous System Prophylaxis
Bag
prophylactic treatment, nos
Prevention
Pouch Dosage Form Category
Post-Exposure prophylaxis
human immunodeficiency virus, nos
HIV
Preventive Intervention
Pouch Dosing Unit
---
https://www.has-sante.fr/jcms/p_3519087/fr/sensura-mio
2024
France
health technology assessment
urinary tract, nos
Pouch
Twice
equipment and supplies, hospital
numismatics
Urinary System
MLXIPL wt Allele
Stomatocyte Count
Bag
urinary tract
urinary reservoirs, continent
ostomy collection bag
Pouch Dosing Unit
Stoma
Murine Urinary System
coins
Pouch Dosage Form Category
---
https://www.has-sante.fr/jcms/p_3519081/fr/sensura-mio
2024
France
health technology assessment
numismatics
Drug Delivery System
coins
enterostomy
Device System
Pouch
Stomatocyte Count
Pouch Dosage Form Category
Drug Delivery System Category
digestive system
digestive tract function, nos
Pouch Dosing Unit
Twice
Bag
digestant, nos
equipment and supplies, hospital
MLXIPL wt Allele
Digestion
Stoma
ostomy collection bag
---
https://www.has-sante.fr/jcms/p_3519075/fr/sensura-mio
2024
France
health technology assessment
digestant, nos
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
IDH Family Mutation Analysis Was Not Performed
Norway
IV Anesthesia was not Administered
Additional Surgery for New Metastatic Tumor Event Was Not Performed
No History of Kawasaki Disease
No Known History of Illicit Drug Use
First Degree Family History of Primary Brain Tumor Negative
Minor Criteria for Rheumatic Heart Disease Not Present
Bag
Nitric Oxide Measurement
No History of Neonatal Complication
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
MGMT Promoter Methylation Testing Was Not Performed
Device System
Pouch Dosing Unit
NRAS Mutation Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
ERBB2 Mutation Analysis Was Not Performed
Documentation Absent
First Degree Family History Thyroid Cancer Negative
RET Rearrangement Analysis Was Not Performed
Regional Anesthesia was not Administered
No History of Non-Cardiac Surgery
KIT Mutation Analysis Was Not Performed
Drug Delivery System
IDH Family Wildtype
Another Form of Birth Control was not Used
digestion
No History of Gestational Complication
Pouch
Stoma
Not Lost to Follow-Up
1p/19q Deletion Analysis Was Not Performed
Preoperative IV Opiates were not Administered
EGFR Amplification Analysis Was Not Performed
numismatics
New Tumor Event After Initial Treatment Absent
Adjuvant Post-operative Radiation Therapy Was Not Administered
MET Mutation Analysis Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Lymph Node Dissection Was Not Performed
MLXIPL wt Allele
ATRX Mutation Analysis Was Not Performed
Chief Complaint was Not Witnessed
Intercurrent Illness is Absent at Onset of Chief Complaint
Preoperative IV Sedation was Not Administered
No Known History of Alcohol Use
digestants
Cancer History Absent
Hypertension Absent
PTEN Mutation Analysis Was Not Performed
Routine Cytogenetics Were not Completed
Negation
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Congenital Heart Disease
EGFR Gene Amplification Negative
Twice
Any Metastatic Diagnosis Absent
Family History of Stomach Cancer Absent
Additional Surgery for New Tumor Event Absent
ATRX Gene Mutation Negative
Local Anesthesia Agents were not Administered
Additional Immunohistochemistry Was Not Performed
enterostomy
First Degree Family History Cancer Negative
Intervention Not Given for Kawasaki Disease
Neither Case or Control Status
Nitric Oxide
Adjuvant Post-operative Chemotherapy Was Not Administered
digestive tract function, nos
PTEN Gene Mutation Negative
Has No Sibling
Adjuvant Post-operative Immunological Therapy Was Not Administered
History of Medical Treatment Absent
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Digestion
Preoperative IV Antiemetics were not Administered
Chemotherapy Not Received
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Unemployed
Preoperative IV Antacids were not Administered
Other Preoperative IV Medications were not Administered
Adjuvant I-131 Therapy Negative
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
stoma site, nos
ALK Rearrangement Analysis Was Not Performed
Stomatocyte Count
Medication Not Taken
No History of Myopathy
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Neither
PDGFRA Mutation Analysis Was Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Drug Delivery System Category
Pouch Dosage Form Category
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Chief Complaint Not Caused by Trauma
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event
NON Mouse
TP53 Mutation Analysis Was Not Performed
Patient was not Postmenopausal with no Prior Oophorectomy
Chemical/Occupational Exposure Absent
coins
SDH Complex Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
Therapeutic Ionizing Radiation to Head History Absent
BRAF Mutation Analysis Was Not Performed
Radiation History Negative
No History of Rheumatic Fever
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
equipment and supplies, hospital
Physician Diagnosed Diabetes Absent
EGFR Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
History of Colorectal Cancer Negative
Tumor Progression Absent After Initial Treatment
Use of Smokeless Tobacco at Time of Diagnosis Negative
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Patient was Not Previously Evaluated for Current Chief Complaint
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Radiation Therapy Not Received
New Disease is not Multifocal
BRAF Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Additional Molecular Studies Were Not Performed
No Response to Intervention for Kawasaki Disease
Paraneoplastic Syndrome is Not Present
Caffeine Not Routinely Consumed
10q23/PTEN Locus Deletion Analysis Was Not Performed
NF1 Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Fluorescence In Situ Hybridization Was Not Performed
---